PL314008A1 - Derivatives of flavine as antiviral agents - Google Patents
Derivatives of flavine as antiviral agentsInfo
- Publication number
- PL314008A1 PL314008A1 PL94314008A PL31400894A PL314008A1 PL 314008 A1 PL314008 A1 PL 314008A1 PL 94314008 A PL94314008 A PL 94314008A PL 31400894 A PL31400894 A PL 31400894A PL 314008 A1 PL314008 A1 PL 314008A1
- Authority
- PL
- Poland
- Prior art keywords
- flavine
- derivatives
- antiviral agents
- antiviral
- agents
- Prior art date
Links
- KKAJSJJFBSOMGS-UHFFFAOYSA-N 3,6-diamino-10-methylacridinium chloride Chemical class [Cl-].C1=C(N)C=C2[N+](C)=C(C=C(N)C=C3)C3=CC2=C1 KKAJSJJFBSOMGS-UHFFFAOYSA-N 0.000 title 1
- 239000003443 antiviral agent Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939321558A GB9321558D0 (en) | 1993-10-19 | 1993-10-19 | Anti-viral agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL314008A1 true PL314008A1 (en) | 1996-08-05 |
Family
ID=10743784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL94314008A PL314008A1 (en) | 1993-10-19 | 1994-10-19 | Derivatives of flavine as antiviral agents |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0739208A1 (en) |
| JP (1) | JPH09505804A (en) |
| CN (1) | CN1140992A (en) |
| AP (1) | AP620A (en) |
| AU (1) | AU7943794A (en) |
| BG (1) | BG100599A (en) |
| BR (1) | BR9407862A (en) |
| CA (2) | CA2123825A1 (en) |
| CO (1) | CO4520283A1 (en) |
| CZ (1) | CZ113796A3 (en) |
| EE (1) | EE9600057A (en) |
| GB (2) | GB9321558D0 (en) |
| HR (1) | HRP940688A2 (en) |
| HU (1) | HUT76322A (en) |
| IL (1) | IL111338A0 (en) |
| JO (1) | JO1866B1 (en) |
| MA (1) | MA23356A1 (en) |
| MD (1) | MD960168A (en) |
| NO (1) | NO961547L (en) |
| OA (1) | OA10579A (en) |
| PE (1) | PE5596A1 (en) |
| PL (1) | PL314008A1 (en) |
| SK (1) | SK50696A3 (en) |
| UY (1) | UY23844A1 (en) |
| WO (1) | WO1995011028A1 (en) |
| ZA (1) | ZA948191B (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07188052A (en) * | 1993-12-27 | 1995-07-25 | Sanwa Kagaku Kenkyusho Co Ltd | Interferon activity-enhancing agent and antivirus activity-enhancing composition containing the enhancing agent and interferon |
| US5756479A (en) * | 1994-12-29 | 1998-05-26 | Research Development Foundation | Flavin adenine dinucleotide analogue inhibitors of monoamine oxidase |
| US7498156B2 (en) | 1998-07-21 | 2009-03-03 | Caridianbct Biotechnologies, Llc | Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components |
| US7049110B2 (en) | 1998-07-21 | 2006-05-23 | Gambro, Inc. | Inactivation of West Nile virus and malaria using photosensitizers |
| US7220747B2 (en) | 1999-07-20 | 2007-05-22 | Gambro, Inc. | Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer |
| US7094378B1 (en) | 2000-06-15 | 2006-08-22 | Gambro, Inc. | Method and apparatus for inactivation of biological contaminants using photosensitizers |
| US9044523B2 (en) | 2000-06-15 | 2015-06-02 | Terumo Bct, Inc. | Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light |
| EP1531823A4 (en) * | 2002-05-10 | 2007-07-18 | Univ Ohio State | FLAVIN N-OXIDES: ANTI-CANCER AGENTS AND PATHOGENES ERADICATION AGENTS |
| ITTO20020622A1 (en) | 2002-07-16 | 2004-01-16 | Dayco Europe Srl | INTEGRATED PULLEY-TORSIONAL DAMPER GROUP |
| AU2003257778A1 (en) * | 2002-08-02 | 2004-02-23 | Shenzhen Salubris Pharmaceuticals Co., Ltd. | A riboflavin derivative and its manufacture and uses |
| EP2545788A1 (en) * | 2011-07-13 | 2013-01-16 | Martin Hulliger | Dietary multi-component system |
| JP2018131410A (en) * | 2017-02-15 | 2018-08-23 | ヒノキ新薬株式会社 | Caspase-3 inhibitor and use thereof |
| CU20200039A7 (en) * | 2017-10-24 | 2021-03-11 | Lunella Biotech Inc | MITOFLAVOSCINS: TARGETING BINDING OF ENZYMES CONTAINING FLAVIN KILLS CANCER STEM CELLS (CSCS) BY INHIBITING MITOCHRONDRIAL RESPIRATION |
| JP2022540330A (en) * | 2019-07-09 | 2022-09-15 | ディーエスエム アイピー アセッツ ビー．ブイ． | Reduction of Viral Activity of Elafibranol by Riboflavin or DHA |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4219545A (en) * | 1979-03-23 | 1980-08-26 | Collins Calvin E | Treatment of infectious keratoconjunctivitis in animals |
| US4264601A (en) * | 1979-06-12 | 1981-04-28 | The Board Of Regents Of The University Of Oklahoma | Antihypertensive agents and their use in treatment of hypertension |
| US4500524A (en) * | 1982-09-15 | 1985-02-19 | Trustees Of Boston University | Tranquilizing and reducing or preventing seizures |
| WO1991002529A2 (en) * | 1989-08-14 | 1991-03-07 | John Bennett Kizer | Product and method for killing abnormal vertebrate cells |
| JP2727471B2 (en) * | 1989-09-14 | 1998-03-11 | 三井農林株式会社 | Influenza virus infection prevention agent |
| US5192264A (en) * | 1989-10-06 | 1993-03-09 | The Beth Israel Hospital Association | Methods and apparatus for treating disease states using oxidized lipoproteins |
| US5217716A (en) * | 1990-07-18 | 1993-06-08 | The Beth Israel Hospital Association | Method for treating viral infections using oxidized lipoproteins |
| FR2674753B1 (en) * | 1991-04-02 | 1995-03-10 | Jean Berque | NEW THERAPEUTIC INDICATIONS, PARTICULARLY FOR THE TREATMENT OF AIDS, OF AN ALREADY EXISTING MEDICINAL PRODUCT FROM A DENIMOUS MOLECULE OF CONTRAINDICATIONS AND ADVERSE REACTIONS. |
| NZ244270A (en) * | 1991-09-13 | 1995-07-26 | Eisai Co Ltd | Injectable composition comprising riboflavin |
| WO1993010784A1 (en) * | 1991-11-25 | 1993-06-10 | University Of Michigan | Therapeutic composition and method for preventing reperfusion injury |
| JP3073309B2 (en) * | 1992-03-27 | 2000-08-07 | 雪印乳業株式会社 | Sialic acid-bound 5-deazaflavin compounds |
-
1993
- 1993-10-19 GB GB939321558A patent/GB9321558D0/en active Pending
-
1994
- 1994-01-19 JO JO19941866A patent/JO1866B1/en active
- 1994-05-18 CA CA2123825A patent/CA2123825A1/en active Pending
- 1994-10-18 MA MA23679A patent/MA23356A1/en unknown
- 1994-10-19 UY UY23844A patent/UY23844A1/en unknown
- 1994-10-19 PL PL94314008A patent/PL314008A1/en unknown
- 1994-10-19 IL IL11133894A patent/IL111338A0/en unknown
- 1994-10-19 AU AU79437/94A patent/AU7943794A/en not_active Abandoned
- 1994-10-19 PE PE1994253128A patent/PE5596A1/en not_active Application Discontinuation
- 1994-10-19 SK SK506-96A patent/SK50696A3/en unknown
- 1994-10-19 AP APAP/P/1994/000695A patent/AP620A/en active
- 1994-10-19 CZ CZ961137A patent/CZ113796A3/en unknown
- 1994-10-19 HU HU9601006A patent/HUT76322A/en unknown
- 1994-10-19 CO CO94047671A patent/CO4520283A1/en unknown
- 1994-10-19 EE EE9600057A patent/EE9600057A/en unknown
- 1994-10-19 GB GB9421099A patent/GB2283913A/en not_active Withdrawn
- 1994-10-19 JP JP7511518A patent/JPH09505804A/en active Pending
- 1994-10-19 ZA ZA948191A patent/ZA948191B/en unknown
- 1994-10-19 CN CN94194350A patent/CN1140992A/en active Pending
- 1994-10-19 WO PCT/GB1994/002292 patent/WO1995011028A1/en not_active Application Discontinuation
- 1994-10-19 EP EP94930272A patent/EP0739208A1/en not_active Withdrawn
- 1994-10-19 BR BR9407862A patent/BR9407862A/en not_active Application Discontinuation
- 1994-10-19 CA CA002174552A patent/CA2174552A1/en not_active Abandoned
- 1994-10-19 HR HR9321558.0A patent/HRP940688A2/en not_active Application Discontinuation
-
1996
- 1996-04-18 OA OA60815A patent/OA10579A/en unknown
- 1996-04-18 NO NO961547A patent/NO961547L/en unknown
- 1996-05-17 MD MD96-0168A patent/MD960168A/en not_active Application Discontinuation
- 1996-05-17 BG BG100599A patent/BG100599A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU9601006D0 (en) | 1996-06-28 |
| GB9321558D0 (en) | 1993-12-08 |
| BR9407862A (en) | 1997-05-20 |
| CA2174552A1 (en) | 1995-04-27 |
| JPH09505804A (en) | 1997-06-10 |
| PE5596A1 (en) | 1996-04-18 |
| UY23844A1 (en) | 1995-03-28 |
| BG100599A (en) | 1997-02-28 |
| WO1995011028A1 (en) | 1995-04-27 |
| JO1866B1 (en) | 1995-12-27 |
| CZ113796A3 (en) | 1996-11-13 |
| SK50696A3 (en) | 1997-01-08 |
| MA23356A1 (en) | 1995-07-01 |
| CN1140992A (en) | 1997-01-22 |
| MD960168A (en) | 1998-04-30 |
| ZA948191B (en) | 1995-06-08 |
| GB2283913A (en) | 1995-05-24 |
| CA2123825A1 (en) | 1995-04-20 |
| GB9421099D0 (en) | 1994-12-07 |
| EE9600057A (en) | 1996-10-15 |
| NO961547L (en) | 1996-06-19 |
| NO961547D0 (en) | 1996-04-18 |
| EP0739208A1 (en) | 1996-10-30 |
| HUT76322A (en) | 1997-08-28 |
| AU7943794A (en) | 1995-05-08 |
| AP620A (en) | 1997-10-14 |
| OA10579A (en) | 2002-06-19 |
| AP9400695A0 (en) | 1995-01-31 |
| IL111338A0 (en) | 1994-12-29 |
| HRP940688A2 (en) | 1997-04-30 |
| CO4520283A1 (en) | 1997-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL313619A1 (en) | Derivatives of piperydine | |
| PL310443A1 (en) | Derivatives of pyrolo-pyridine | |
| EP0445098A3 (en) | Deoxynojirimycin derivatives as antiviral agents | |
| PL329177A1 (en) | Derivatives of azahexane ehxibiting antiviral activity | |
| PL307812A1 (en) | Substituted thiazolydinone derivatives | |
| PL306127A1 (en) | Derivatives of epi-epibathydine | |
| HU9501809D0 (en) | Antiviral indole derivatives | |
| LTIP1874A (en) | Substituted azolone derivatives | |
| PL314008A1 (en) | Derivatives of flavine as antiviral agents | |
| AU7623991A (en) | Antiviral agents | |
| GB9420114D0 (en) | Substituted cyclic derivatives as novel antidegenerative agents | |
| GB9320785D0 (en) | Dibenzylheterocyclic or dibenzylcycloalkyl derivatives as inhibitors of hiv intergrase | |
| HU9501856D0 (en) | Purine derivatives | |
| HU9503281D0 (en) | Thioindole pyperidinyl derivatives used as antalgics | |
| PL306204A1 (en) | Novel derivatives of imidazopyrimidine | |
| ZA947258B (en) | Novel triaryl-ethylene derivatives | |
| EP0583161A3 (en) | 4-aminopyrrole-2-carboxamide derivatives as antiviral agents | |
| GB9320940D0 (en) | Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative agents | |
| AU1699992A (en) | Dibenzothiazepinthione as antiviral agents | |
| AU4347596A (en) | Thienoxazinone derivatives useful as antiviral agents | |
| AU4167293A (en) | Heterocyclyl-phenoxyalkyl-piperidinylpyridazines as antiviral agents | |
| AU4290993A (en) | Michellamines useful as antiviral agents | |
| PL316985A1 (en) | Derivatives of adenosine | |
| EP0468927A3 (en) | Derivatives of carboxymethylcyclopropane | |
| ZA948297B (en) | Pyrimidine derivatives |